The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity

Anti-HER2/neu antibody therapy is reported to mediate tumor regression by interrupting oncogenic signals and/or inducing FcR-mediated cytotoxicity. Here, we demonstrate that the mechanisms of tumor regression by this therapy also require the adaptive immune response. Activation of innate immunity an...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Park, SaeGwang, Jiang, Zhujun, Mortenson, Eric D., Deng, Liufu, Radkevich-Brown, Olga, Yang, Xuanming, Sattar, Husain, Wang, Yang, Brown, Nicholas K., Greene, Mark, Liu, Yang, Tang, Jie, Wang, Shengdian, Fu, Yang-Xin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2923645/
https://ncbi.nlm.nih.gov/pubmed/20708157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2010.06.014
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller